Distribution Threat to Viz AI

The real threat from imaging incumbents is distribution, not algorithm quality. GE HealthCare, Siemens Healthineers, and Philips already sell the scanners, service contracts, and software that radiology departments buy together, so they can add AI as one more box on a larger purchase order. That makes hospital adoption easier for bundled tools, while Viz.ai has to win a separate software budget by proving faster triage, better coordination, and measurable clinical ROI.

• Incumbents start with procurement leverage. Hospitals already buy scanners, maintenance, upgrades, and informatics from these vendors over multi year cycles. Adding AI into that package can feel like extending an existing vendor relationship, not introducing a new system, which lowers sales friction.
  1 sacra 2 fda 3 gehealthcare 4 siemenshealthineers
• Their AI is also being embedded close to the image itself. GE has led the FDA tally of AI enabled device authorizations, Siemens has expanded AI-Rad Companion across imaging workflows, and Philips has paired MRI hardware with partner software for neuro decision support. That lets AI arrive pre integrated with imaging workflows.
  2 fda 3 gehealthcare 4 siemenshealthineers 5 philips
• Viz.ai competes differently. Its product does not just flag an abnormal scan, it routes the case to the right specialists on mobile, lets teams review images together, and speeds transfer and treatment decisions. That workflow layer is why Viz.ai has reached nearly 2,000 hospitals and expanded from stroke into pulmonary, aortic, oncology, and life sciences use cases.
  1 sacra

The market is heading toward two layers. Scanner vendors will keep folding more AI into imaging hardware and reading software, while Viz.ai pushes higher into the clinical workflow where care teams coordinate action after the scan. The winner will be the company that becomes hardest to remove from the hospital's daily path from image to treatment.